RARE
Price
$35.38
Change
-$0.60 (-1.67%)
Updated
May 9, 03:28 PM (EDT)
Capitalization
3.16B
83 days until earnings call
TNGX
Price
$1.10
Change
-$0.05 (-4.35%)
Updated
May 8 closing price
Capitalization
124.32M
3 days until earnings call
Ad is loading...

RARE vs TNGX

Header iconRARE vs TNGX Comparison
Open Charts RARE vs TNGXBanner chart's image
Ultragenyx Pharmaceutical
Price$35.38
Change-$0.60 (-1.67%)
Volume$700
Capitalization3.16B
Tango Therapeutics
Price$1.10
Change-$0.05 (-4.35%)
Volume$500.84K
Capitalization124.32M
RARE vs TNGX Comparison Chart
Loading...
RARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RARE vs. TNGX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RARE is a Buy and TNGX is a Hold.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (RARE: $35.98 vs. TNGX: $1.10)
Brand notoriety: RARE and TNGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RARE: 197% vs. TNGX: 71%
Market capitalization -- RARE: $3.16B vs. TNGX: $124.32M
RARE [@Biotechnology] is valued at $3.16B. TNGX’s [@Biotechnology] market capitalization is $124.32M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RARE’s FA Score shows that 0 FA rating(s) are green whileTNGX’s FA Score has 1 green FA rating(s).

  • RARE’s FA Score: 0 green, 5 red.
  • TNGX’s FA Score: 1 green, 4 red.
According to our system of comparison, TNGX is a better buy in the long-term than RARE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RARE’s TA Score shows that 6 TA indicator(s) are bullish while TNGX’s TA Score has 4 bullish TA indicator(s).

  • RARE’s TA Score: 6 bullish, 4 bearish.
  • TNGX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RARE is a better buy in the short-term than TNGX.

Price Growth

RARE (@Biotechnology) experienced а -7.67% price change this week, while TNGX (@Biotechnology) price change was -21.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.95%. For the same industry, the average monthly price growth was +10.02%, and the average quarterly price growth was -14.02%.

Reported Earning Dates

RARE is expected to report earnings on Jul 31, 2025.

TNGX is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (-5.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RARE($3.16B) has a higher market cap than TNGX($124M). RARE YTD gains are higher at: -14.476 vs. TNGX (-64.401). TNGX has higher annual earnings (EBITDA): -143.1M vs. RARE (-469M). RARE has more cash in the bank: 610M vs. TNGX (258M). TNGX has less debt than RARE: TNGX (36.5M) vs RARE (40.3M). RARE has higher revenues than TNGX: RARE (560M) vs TNGX (42.1M).
RARETNGXRARE / TNGX
Capitalization3.16B124M2,548%
EBITDA-469M-143.1M328%
Gain YTD-14.476-64.40122%
P/E RatioN/AN/A-
Revenue560M42.1M1,330%
Total Cash610M258M236%
Total Debt40.3M36.5M110%
FUNDAMENTALS RATINGS
RARE: Fundamental Ratings
RARE
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RARETNGX
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 10 days ago
77%
Bullish Trend 18 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 2 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
RARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RNPCX61.260.13
+0.21%
American Funds New Perspective R3
EALCX39.07N/A
N/A
Eaton Vance Growth A
MGRPX56.15N/A
N/A
Morgan Stanley Inst Growth R6
OANGX33.75N/A
N/A
Oakmark Global Institutional
GPIGX12.69N/A
N/A
Guidepath® Growth and Income

TNGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNGX has been loosely correlated with AXON. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TNGX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNGX
1D Price
Change %
TNGX100%
-4.35%
AXON - TNGX
41%
Loosely correlated
+14.13%
MDGL - TNGX
39%
Loosely correlated
+0.25%
BNTC - TNGX
36%
Loosely correlated
+1.48%
RARE - TNGX
36%
Loosely correlated
+7.66%
ORMP - TNGX
36%
Loosely correlated
+3.15%
More